Litigation Details for Silvergate Pharmaceuticals, Inc. v. Bionpharma Inc. (D. Del. 2018)
✉ Email this page to a colleague
Silvergate Pharmaceuticals, Inc. v. Bionpharma Inc. (D. Del. 2018)
Docket | ⤷ Try a Trial | Date Filed | 2018-12-11 |
Court | District Court, D. Delaware | Date Terminated | 2021-05-17 |
Cause | 35:271 Patent Infringement | Assigned To | Leonard Philip Stark |
Jury Demand | None | Referred To | |
Parties | BIONPHARMA INC. | ||
Patents | 10,039,745; 10,154,987; 10,183,004; 10,232,003; 10,279,012; 10,279,014; 6,168,016; 6,211,244; 6,316,460; 8,183,002; 8,222,015; 8,568,747; 9,194,011; 9,242,011; 9,297,019; 9,375,405; 9,669,008; 9,808,442 | ||
Attorneys | Kristina A. Hanson | ||
Firms | Morris, Nichols, Arsht & Tunnell | ||
Link to Docket | External link to docket |
Small Molecule Drugs cited in Silvergate Pharmaceuticals, Inc. v. Bionpharma Inc.
Biologic Drugs cited in Silvergate Pharmaceuticals, Inc. v. Bionpharma Inc.
The biologic drugs covered by the patents cited in this case are ⤷ Try a Trial , ⤷ Try a Trial , ⤷ Try a Trial , ⤷ Try a Trial , ⤷ Try a Trial , ⤷ Try a Trial , ⤷ Try a Trial , ⤷ Try a Trial , ⤷ Try a Trial , ⤷ Try a Trial , ⤷ Try a Trial , ⤷ Try a Trial , ⤷ Try a Trial , ⤷ Try a Trial , ⤷ Try a Trial , ⤷ Try a Trial , ⤷ Try a Trial , ⤷ Try a Trial , ⤷ Try a Trial , and ⤷ Try a Trial .
Details for Silvergate Pharmaceuticals, Inc. v. Bionpharma Inc. (D. Del. 2018)
Date Filed | Document No. | Description | Snippet | Link To Document |
---|---|---|---|---|
2020-12-13 | and Counterclaims with Respect to U.S. Patent Nos. 9,669,008 and 9,808,442 filed by Silvergate Pharmaceuticals… 2018 17 May 2021 1:18-cv-01962 835 Patent - Abbreviated New Drug Application(ANDA) None | External link to document | ||
2020-07-22 | 136 | Notice of Service | Byrn on Infringement of U.S. Patent Nos. 9,669,008; 9,808,442; 10,039,745; and 10,154,987; and (2) Opening…John D. Mahan, Jr., M.D. on Infringement of U.S. Patent 9,808,442 and 10,154,987 filed by Silvergate Pharmaceuticals… 2018 17 May 2021 1:18-cv-01962 835 Patent - Abbreviated New Drug Application(ANDA) None | External link to document |
2020-10-19 | 145 | Notice of Service | Stephen Byrn on the Infringement of U.S. Patents 10,039,745 and 10,154,987 filed by Silvergate Pharmaceuticals… 2018 17 May 2021 1:18-cv-01962 835 Patent - Abbreviated New Drug Application(ANDA) None | External link to document |
2020-10-30 | 147 | Attachment 2 | accord D.I. 353 at 182:10-183:4). C. Prosecution of the ’405 Patent 1. …two new patents. Amneal and Bionpharma were coordinated as to the first four Epaned patents for good… first set of Epaned patents to issue (the ’008, ’442, ’745, and ’987 patents). (C.A. No. 19-678 against…involves two patents that did not issue until September 2020 (the ’868 and ’482 patents), but that are…asserts the same six patents against both Amneal and Bionpharma. All six patents deal with the same technology | External link to document |
2020-12-09 | 166 | Stipulation of Dismissal | and Counterclaims with Respect to U.S. Patent Nos. 9,669,008 and 9,808,442 by Silvergate Pharmaceuticals… 2018 17 May 2021 1:18-cv-01962 835 Patent - Abbreviated New Drug Application(ANDA) None | External link to document |
2019-10-31 | 22 | Proposed Order | 19-1067, which relates to asserted U.S. Patent No. 10,154,987, should also be included herein with the…and Judge Stark’s Revised Procedures for Managing Patent Cases (which is posted at 1 The parties…www.ded.uscourts.gov; see Chambers, Judge Leonard P. Stark, Patent Cases), and the parties having determined after…Identification of Accused Product(s) and Asserted Patent(s). By December… and the asserted patent(s) they alleged infringe, and produce the | External link to document |
2021-04-22 | 251 | 200:7, 190:10, 190:24, 231:10, 232:3, INC [3] - 163:3, 163:6, 276:19 …288:15 studied [1] - 248:15 231:10, 232:3, sorbate [1] - 304:24 squares [1…across four patents: the '008, '442, '745, and '987 9 patents. 10… Two patents essentially cover the oral liquid 11 formulation, two other patents cover methods…across two patents asserted 21 against Bionpharma: The '745 and '987 patent. | External link to document | |
>Date Filed | >Document No. | >Description | >Snippet | >Link To Document |